EdgarScope

Free, fast access to the SEC EDGAR database. Search 10-K, 10-Q and 8-K filings for every registered U.S. public company.

Browse

Filing Search
All Tickers A–Z
About EdgarScope

Related Research

A filing tells you what happened. For what it means, our companion site breaks down U.S. earnings reports, dividend screens and beginner-friendly algorithmic trading strategies.

FNReportU.S. Equity Insights · written in Korean

© 2026 EdgarScope. Filing data is sourced from the U.S. Securities and Exchange Commission EDGAR system. EdgarScope is an independent service and is not affiliated with, endorsed by, or sponsored by the SEC. Nothing on this site constitutes investment advice.

RLMD SEC Filings | SEC Document SEARCH

RELMADA THERAPEUTICS, INC. (RLMD)

Ticker: RLMDCIK: 0001553643

30

Filings Found (Last 1 Year)

42026. 9. 9.

Shenouda Maged (CIK 0001658369)

Insider trading reportOWNERSHIP DOCUMENT

42026. 9. 9.

TRAVERSA SERGIO (CIK 0001565832)

Insider trading report

8-K2026. 9. 3.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

8-K2026. 8. 6.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

10-Q2026. 6. 30.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Quarterly reportQUARTERLY REPORT

8-K2026. 7. 28.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

8-K2026. 5. 27.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

8-K2026. 5. 12.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

10-Q2026. 3. 31.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Quarterly reportQUARTERLY REPORT

8-K2026. 3. 19.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

10-K2025. 12. 31.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Annual reportANNUAL REPORT

8-K2026. 3. 9.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

424B52026. 1. 30.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

ProspectusPROSPECTUS SUPPLEMENT

42025. 12. 12.

TRAVERSA SERGIO (CIK 0001565832)

Insider trading report

42025. 12. 12.

Shenouda Maged (CIK 0001658369)

Insider trading report

42025. 12. 12.

Ence Chuck (CIK 0001697779)

Insider trading report

42025. 12. 12.

Fedeli Fabiana (CIK 0001961902)

Insider trading report

42025. 12. 12.

GLASSPOOL JOHN (CIK 0001644079)

Insider trading report

42025. 12. 12.

Kelly Paul Edward (CIK 0001658544)

Insider trading report

42025. 12. 12.

CASAMENTO CHARLES J (CIK 0001117167)

Insider trading report

8-K2025. 12. 12.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

8-K2025. 11. 13.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

10-Q2025. 9. 30.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Quarterly reportQUARTERLY REPORT

42025. 11. 5.

Ence Chuck (CIK 0001697779)

Insider trading report

42025. 11. 5.

TRAVERSA SERGIO (CIK 0001565832)

Insider trading report

42025. 11. 5.

Shenouda Maged (CIK 0001658369)

Insider trading report

42025. 11. 5.

Kelly Paul Edward (CIK 0001658544)

Insider trading report

8-K2025. 11. 4.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

424B52025. 11. 5.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

ProspectusPROSPECTUS SUPPLEMENT

8-K2025. 11. 4.

RELMADA THERAPEUTICS, INC. (RLMD) (CIK 0001553643)

Current reportCURRENT REPORT

PreviousPage 5 of 2Next